Jiangsu Changqing benefits from increases in imidacloprid price in 2017

Summary: Jiangsu Changqing realised YoY increase in net profit in 2017, mainly due to high price of its leading product, imidacloprid TC. In order to maintain increases in sales, it is working to enlarge its product line by building new projects. In ...

More from CCM